Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin (Q34392462)

1 August 2017

title

Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin (English)

1 reference

1 August 2017

0 references

0 references

Brynskov J

1

1 reference

1 August 2017

Tvede N

series ordinal

2

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 1990

1 reference

1 August 2017

1 reference

1 August 2017

volume

31

1 reference

1 August 2017

issue

7

1 reference

1 August 2017

page(s)

795-799

1 reference

The interleukin-2 T-cell system: a new cell growth model.

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378538

Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378538

Soluble interleukin-2 receptors in systemic lupus erythematosus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378538

Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378538

Interleukin 2 high-affinity receptor expression requires two distinct binding proteins

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378538

Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378538

Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378538

The released interleukin 2 receptor binds interleukin 2 efficiently

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378538

High-affinity receptor-mediated internalization and degradation of interleukin 2 in human T cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378538

Interleukin 2 regulates its own receptors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378538

A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378538

Low-dose cyclosporin for Crohn's disease: implications for clinical trials.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378538

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378538

Cyclosporin for the treatment of severe inflammatory bowel disease

6 July 2018

1 reference

12 December 2020

Involvement of the immune system in the pathogenesis of Crohn's disease. Expression of the T9 antigen on peripheral immunocytes correlates with the severity of the disease

1 reference

12 December 2020

A monoclonal antibody 7G7/B6, binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac

1 reference

12 December 2020

Cytokine production in inflammatory bowel disease

1 reference

12 December 2020

A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells

1 reference

12 December 2020

Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease

1 reference

12 December 2020

Immunology of inflammatory bowel disease

1 reference

12 December 2020

An analysis of the cellular requirements for the production of soluble interleukin-2 receptors in vitro

1 reference

12 December 2020

Cyclosporin. Mechanism of action: in vitro studies

1 reference

12 December 2020

Peripheral blood mononuclear-cell interleukin-2 production, receptor generation and lymphokine-activated cytotoxicity in inflammatory bowel disease

1 reference

12 December 2020

Plasma interleukin 2 receptor levels in renal allograft recipients

1 reference

12 December 2020

Biochemical and functional analysis of soluble human interleukin-2 receptor produced in rodent cells. Solid-phase reconstitution of a receptor-ligand binding reaction

1 reference

12 December 2020

Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus

1 reference

12 December 2020

Soluble Tac peptide is present in the urine of normal individuals and at elevated levels in patients with adult T cell leukaemia (ATL)

1 reference

12 December 2020

Soluble interleukin-2 receptors in serum and bile of liver transplant recipients

1 reference

12 December 2020

Increased serum soluble interleukin 2 receptor levels in patients with viral liver diseases

1 reference

12 December 2020

T-cell abnormalities in inflammatory bowel disease are mediated by interleukin 2

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.31.7.795

1 reference

release_tuuurl6hlbhztgiq4ejdwlkmi4

1 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tuuurl6hlbhztgiq4ejdwlkmi4

24 November 2022

mapped directly with Wikidata item

PMC publication ID

1378538

1 reference

1 August 2017

1 reference